Novel Therapeutic Agents for Resistant Gram-Positive Infections
Journal:
Current Drug Therapy
Volume:
3
Page:
98-110
Author(s):
Roberto Manfredi and Leonardo Calza
Potential Benefits of Glitazones for Cancer and Vascular Disease
Journal:
Current Drug Therapy
Volume:
3
Page:
111-125
Author(s):
Jose M. Perez-Ortiz, Silvia Llorens, Juan Llopis, Pedro A. Tranque and Eduardo Nava
Molecular Genetics and Biomarkers of Polyglutamine Diseases
Journal:
Current Molecular Medicine
Volume:
8
Page:
221-234
Author(s):
Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Fumiaki Tanaka, Hiroaki Adachi and Gen Sobue
Bacterial Protein Toxins: Current and Potential Clinical Use
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1116-1125
Author(s):
A. Fabbri, S. Travaglione, L. Falzano and C. Fiorentini
BK Channel Modulators: A Comprehensive Overview
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1126-1146
Author(s):
Antonio Nardi and Soren-Peter Olesen
Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
77-84
Author(s):
Giuseppe Derosa and Sibilla A.T. Salvadeo
A SELDI-TOF-MS Study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping
Journal:
Current Neurovascular Research
Volume:
5
Page:
93-98
Author(s):
Julie Staals, Judith A.P. Bons, Robert J. van Oostenbrugge, Iris L.H. Knottnerus, Marja P. van Dieijen-Visser, Freek G. Bouwman, Edwin C. Mariman, Joris R. Delanghe, Jan Lodder and Will K.W.H. Wodzig
Association of Soluble Adhesion Molecule and C-Reactive Protein Levels with Silent Brain Infarction in Patients with and Without Type 2 Diabetes
Journal:
Current Neurovascular Research
Volume:
5
Page:
106-111
Author(s):
Toshitaka Umemura, Takahiko Kawamura, Toshimasa Sakakibara, Akio Kanai, Takahisa Sano, Nigishi Hotta and Gen Sobue
Erythropoietin and Oxidative Stress
Journal:
Current Neurovascular Research
Volume:
5
Page:
125-142
Author(s):
Kenneth Maiese, Zhao Zhong Chong, Jinling Hou and Yan Chen Shang
A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1500-1511
Author(s):
Patrizia Popoli, David Blum, Maria Rosaria Domenici, Sylvie Burnouf and Yijuang Chern